DK2812025T3 - PROCEDURE FOR PREVENTING ALLERGIES - Google Patents
PROCEDURE FOR PREVENTING ALLERGIES Download PDFInfo
- Publication number
- DK2812025T3 DK2812025T3 DK13702074.9T DK13702074T DK2812025T3 DK 2812025 T3 DK2812025 T3 DK 2812025T3 DK 13702074 T DK13702074 T DK 13702074T DK 2812025 T3 DK2812025 T3 DK 2812025T3
- Authority
- DK
- Denmark
- Prior art keywords
- allergen
- child
- allergy
- milk
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261595577P | 2012-02-06 | 2012-02-06 | |
| EP12305153.4A EP2626082A1 (en) | 2012-02-13 | 2012-02-13 | Method of preventing allergies |
| PCT/EP2013/052163 WO2013117519A1 (en) | 2012-02-06 | 2013-02-04 | Method of preventing allergies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2812025T3 true DK2812025T3 (en) | 2017-10-30 |
Family
ID=45656814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13702074.9T DK2812025T3 (en) | 2012-02-06 | 2013-02-04 | PROCEDURE FOR PREVENTING ALLERGIES |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20140377311A1 (hu) |
| EP (3) | EP2626082A1 (hu) |
| JP (1) | JP6193266B2 (hu) |
| KR (1) | KR102072683B1 (hu) |
| CN (1) | CN104114185B (hu) |
| AU (2) | AU2013218164A1 (hu) |
| CA (1) | CA2862568C (hu) |
| DK (1) | DK2812025T3 (hu) |
| ES (2) | ES2644118T3 (hu) |
| HU (1) | HUE036962T2 (hu) |
| IL (1) | IL233596B (hu) |
| PT (1) | PT2812025T (hu) |
| WO (1) | WO2013117519A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| CA2773234C (en) | 2009-09-07 | 2017-11-28 | Dbv Technologies | Method of treating eosinophilic esophagitis |
| MX2016009306A (es) * | 2014-01-17 | 2017-04-10 | Dbv Tech | Reequilibrado inmunologico epicutaneo. |
| US10872313B2 (en) | 2015-06-02 | 2020-12-22 | ROCA Medical Ltd. | Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy |
| EP2952200A1 (en) * | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
| US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10369215B2 (en) | 2015-06-02 | 2019-08-06 | ROCA Medical Ltd. | Predilution sets for distributing antigens |
| US20160362205A1 (en) * | 2015-06-02 | 2016-12-15 | ROCA Medical Ltd. | Use of autoinjector for distributing antigens to the public |
| US10548974B2 (en) | 2015-06-02 | 2020-02-04 | ROCA Medical Ltd. | Therapeutic treatment kit for allergies based on DNA profiles |
| CN111465328A (zh) | 2017-07-18 | 2020-07-28 | 前品牌股份有限公司 | 制备混合型变应原组合物的方法 |
| WO2019112808A1 (en) | 2017-12-06 | 2019-06-13 | Prollergy Corporation | Composition and method for reducing allergic response |
| US11766477B2 (en) | 2019-01-23 | 2023-09-26 | Societe Des Produits Nestle S.A. | Methods for making mixed allergen compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7635488B2 (en) | 2001-03-13 | 2009-12-22 | Dbv Technologies | Patches and uses thereof |
| FR2822049B1 (fr) | 2001-03-13 | 2003-08-01 | Dbv Medica 1 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation |
| WO2007059979A2 (en) * | 2005-11-23 | 2007-05-31 | Universität Zürich | Allergy treatment by epicutaneous allergen administration |
| FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| WO2009142772A2 (en) * | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
-
2012
- 2012-02-13 EP EP12305153.4A patent/EP2626082A1/en not_active Withdrawn
-
2013
- 2013-02-04 CA CA2862568A patent/CA2862568C/en active Active
- 2013-02-04 ES ES13702074.9T patent/ES2644118T3/es active Active
- 2013-02-04 JP JP2014555246A patent/JP6193266B2/ja active Active
- 2013-02-04 CN CN201380008175.0A patent/CN104114185B/zh active Active
- 2013-02-04 EP EP13702074.9A patent/EP2812025B1/en active Active
- 2013-02-04 US US14/373,013 patent/US20140377311A1/en not_active Abandoned
- 2013-02-04 EP EP17180424.8A patent/EP3248616B1/en active Active
- 2013-02-04 ES ES17180424T patent/ES2798378T3/es active Active
- 2013-02-04 WO PCT/EP2013/052163 patent/WO2013117519A1/en active Application Filing
- 2013-02-04 HU HUE13702074A patent/HUE036962T2/hu unknown
- 2013-02-04 KR KR1020147024806A patent/KR102072683B1/ko active IP Right Grant
- 2013-02-04 AU AU2013218164A patent/AU2013218164A1/en not_active Abandoned
- 2013-02-04 DK DK13702074.9T patent/DK2812025T3/en active
- 2013-02-04 PT PT137020749T patent/PT2812025T/pt unknown
-
2014
- 2014-07-10 IL IL233596A patent/IL233596B/en unknown
-
2016
- 2016-06-16 US US15/184,933 patent/US20160324955A1/en not_active Abandoned
-
2017
- 2017-11-03 AU AU2017254938A patent/AU2017254938B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL233596B (en) | 2021-08-31 |
| AU2013218164A1 (en) | 2014-09-18 |
| KR20150035492A (ko) | 2015-04-06 |
| HUE036962T2 (hu) | 2018-08-28 |
| CN104114185B (zh) | 2016-09-07 |
| ES2644118T3 (es) | 2017-11-27 |
| ES2798378T3 (es) | 2020-12-11 |
| CA2862568C (en) | 2020-11-17 |
| EP3248616A1 (en) | 2017-11-29 |
| JP2015508753A (ja) | 2015-03-23 |
| IL233596A0 (en) | 2014-08-31 |
| PT2812025T (pt) | 2017-10-27 |
| EP3248616B1 (en) | 2020-03-25 |
| KR102072683B1 (ko) | 2020-02-03 |
| CN104114185A (zh) | 2014-10-22 |
| AU2017254938B2 (en) | 2019-01-31 |
| EP2626082A1 (en) | 2013-08-14 |
| JP6193266B2 (ja) | 2017-09-06 |
| CA2862568A1 (en) | 2013-08-15 |
| WO2013117519A1 (en) | 2013-08-15 |
| US20160324955A1 (en) | 2016-11-10 |
| EP2812025B1 (en) | 2017-07-19 |
| US20140377311A1 (en) | 2014-12-25 |
| AU2017254938A1 (en) | 2017-11-23 |
| EP2812025A1 (en) | 2014-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017254938B2 (en) | Method of preventing allergies | |
| US8202533B2 (en) | Immunotherapeutic method for increasing groundnut tolerance in a subject | |
| Cox et al. | New directions in immunotherapy | |
| Wachholz et al. | Induction of ‘blocking’IgG antibodies during immunotherapy. | |
| Beignon et al. | Immunization onto bare skin with heat‐labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge | |
| Satitsuksanoa et al. | Modified allergens for immunotherapy | |
| US20190070286A1 (en) | Method of vaccination | |
| WO2012049312A1 (en) | Suppression of a type 1 hypersensitivity immune response with an unrelated antigen | |
| Baker et al. | Could this be it? Epicutaneous, sublingual, and subcutaneous immunotherapy for the treatment of food allergies | |
| Von Moos et al. | The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy | |
| US20070003579A1 (en) | Allergen-specific immunotherapy | |
| AU2004308553A1 (en) | Proteoliposomes and derivatives thereof as cytotoxic response-inducing adjuvants and resulting formulations | |
| Campana et al. | CLINICAL THERAPY RESEARCH INALLERGIC DISEASES | |
| Akdis | Immunologic responses to sublingual allergen immunotherapy |